Autres langues Ind-Swift Laboratories Limited Bombay S.E.

Actions

532305

INE915B01019

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:18:26 25/06/2026			Varia. 5j.	Varia. 1 janv.
201,15 ^INR	+3,93 %		+19,38 %	+128,09 %

28/05	Ind-Swift Laboratories Limited publie ses résultats annuels pour l'exercice clos le 31 mars 2026	CI
07/04	Ind Swift Laboratories : le tribunal rejette l'ensemble des demandes de PI Industries et les demandes reconventionnelles de la société	RE

Autres langues

28/05	Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
07/04	Ind Swift Laboratories says tribunal rejected all claims of PI Industries, counterclaims of co, others
16/02	Ind Swift Laboratories Ltd to invest 400 million rupees in Samba facility upgrade
16/02	Ind-Swift Laboratories Limited to Upgrade Samba Facility with an Investment of 400 Million
31/01	Ind-Swift Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
16/12	Ind-Swift Laboratories' Derabassi Facility Gets GMP Certification from Hungary
14/11	Ind-Swift Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
17/09/25	Emerald Finance Secures Contract to Offer Early-Wage-Access Program; Shares Up 4%
13/08/25	Ind-Swift Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
11/08/25	Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
08/08/25	Ind-Swift Laboratories Limited Completed the acquisition of Ind-Swift Limited.
17/07/25	Ind Swift says NCLT approves amalgamation of Ind-Swift Limited with Ind-Swift Laboratories
04/07/25	Ind-Swift Laboratories Limited Announces Cessation of Prakash Sharma as an Independent Director, Effective from the Close of Business Hours on 4Th July, 2025
18/06/25	IND Swift Laboratories To Invest Up To 950 Mln Rupees In OCRPS Of Khandelwal Finance
30/05/25	Ind-Swift Laboratories Limited Approves Resignation of Param Bir Singh as Non-Executive, Independent Director, Effective May 30, 2025
28/03/25	Ind Swift Laboratories Ltd - Approves Short-Term Advance Of Up To 200 Million Rupees
20/02/25	Ind-Swift Laboratories Names Chief Operating Officer
17/02/25	Ind-Swift Laboratories' Fiscal Q3 Consolidated Net Profit Plunges
13/02/25	Ind-Swift Laboratories Limited Announces Cessation of Ashwani Kumar Vig as Independent Director
02/01/25	Ind-Swift Laboratories Acquires Land in Punjab, India for Planned Facility
01/01/25	Ind-Swift Laboratories Limited Announces Purchase of Land for Setting Up A New State-Of-The-Art Formulations' Facility
10/12/24	Ind-Swift Laboratories Acquires Punjab, India Land for New R&D Center
11/11/24	Ind-Swift Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
11/11/24	Ind-Swift Laboratories Limited announced that it has received INR 786.5 million in funding from Essix Biosciences Limited, Hcp Investments, Zeal Global Opportunities Fund
02/10/24	Ind-Swift Laboratories to Acquire Land in Punjab, India for New Formulations Facility